00553 NANJING PANDA
- 2.550
- +0.040+1.59%
NANJING PANDA News
Nanjing Panda Electronics Co., Ltd. (00553.HK): Net profit for the first quarter - RMB 459.227 million
Gelonghui, April 26, 丨 Nanjing Panda Electronics Co., Ltd. (00553.HK) released its report for the first quarter of 2024, achieving operating income of 484 million yuan, a year-on-year decrease of 13.28%; net profit attributable to shareholders of listed companies - 459.227 million yuan, net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 5.0838 million, and basic earnings per share - 0.0503 yuan.
南京熊貓電子股份：2024年第一季度報告
南京熊貓電子股份：2023年報
Nanjing Panda (600775.SH) reported first-quarter results with a net loss of 45.922,700 yuan
Nanjing Panda (600775.SH) released its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
Nanjing Panda (600775.SH): 80,353 A-share shareholders of the company as of April 19, 2024
Gelonghui, April 23丨Nanjing Panda (600775.SH) said on the investor interactive platform that as of April 19, 2024, the company had 80,353 A-share shareholders, and there was little change in H shares.
Nanjing Panda Electronics Co., Ltd. (00553) was pledged 105 million shares by the controlling shareholder Panda Group
Nanjing Panda Electronics Co., Ltd. (00553) announced that the company received the company's holding shares on April 19, 2024...
Nanjing Panda (600775.SH) controlling shareholder pledges 11.50% of shares
Zhitong Finance App News, Nanjing Panda (600775.SH) issued an announcement. On April 19, 2024, the company received a notice from Panda Electronics Group Co., Ltd. (“Panda Group”), the controlling shareholder of the company, and learned that some of the company's shares were pledged. This time, 105 million shares of the company were pledged, accounting for 49.89% of its shares and 11.50% of the company's total share capital.
The brain-computer interface sector fluctuated and declined. Xiangyu Medical fell by more than 8%, while Aipon Healthcare, Unicharm, Yingqu Technology, Nanjing Panda, and Jiahe Intelligence followed suit.
The brain-computer interface sector fluctuated and declined. Xiangyu Medical fell by more than 8%, while Aipon Healthcare, Unicharm, Yingqu Technology, Nanjing Panda, and Jiahe Intelligence followed suit.
Nanjing Panda Electronics Company Limited's (SHSE:600775) 26% Dip In Price Shows Sentiment Is Matching Revenues
Nanjing Panda Electronics Company Limited (SHSE:600775) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month. Instead of being
Nanjing Panda (600775.SH): As of April 10, 2024, the company's A-share shareholders were 8,3613
Gelonghui, April 12, 丨 Nanjing Panda (600775.SH) said on the investor interactive platform that as of April 10, 2024, the company had 83,613 A-share shareholders, and there was little change in H shares.
Nanjing Panda (600775): Depreciation performance is under pressure to focus on the progress of satellite internet business
Incident: The company released the 2023 annual report forecast. It is expected to achieve net profit of 2,912 million yuan in 2023, YoY -29.90%; realized net profit to mother of 238 million yuan, YoY-696.
Nanjing Panda Electronics Co., Ltd. (00553) announced 2023 results with net loss attributable to mother of approximately 238 million yuan, year-on-year profit to loss
Nanjing Panda Electronics Co., Ltd. (00553) announced its 2023 results, with operating revenue of about 2,912 billion yuan, a year-on-year decrease...
NANJING PANDA: DATE OF BOARD MEETING
NANJING PANDA: 2023 PRELIMINARY ANNUAL RESULTS ANNOUNCEMENT
Nanjing Panda (600775.SH) announced its 2023 annual results, with a net loss of 238 million yuan, changing from profit to loss
According to Zhitong Finance App News, Nanjing Panda (600775.SH) released its 2023 annual report. The company's revenue was 2,912 billion yuan, down 29.90% from the previous year; net loss attributable to shareholders of listed companies was 238 million yuan, from profit to loss; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 257 million yuan, which changed from profit to loss; basic loss per share was 0.2603 yuan/share. The decline in the company's revenue was mainly due to some product restructuring, and the market did not meet expectations; some business delivery cycle adjustments, failure to meet settlement requirements, and some business model changes, and revenue costs declined year-on-year
The A-share brain-computer interface concept continues to decline
Gelonghui March 22 | Chengyitong fell nearly 6%, followed by Nanjing Panda, Boji Healthcare, Innovative Healthcare, and Sanbo Neurology.
Nanjing Panda (600775.SH): As of March 8, 2024, the number of A-shares in the company was 7,6082
Gelonghui, March 12, 丨 Nanjing Panda (600775.SH) said on the investor interactive platform that as of March 8, 2024, the number of A-share accounts in the company was 76,082, and the number of H share shareholders did not change much from month to month.
Is Nanjing Panda Electronics (SHSE:600775) Using Debt In A Risky Way?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
A-share brain-computer interface concept changes, Boji Pharmaceuticals rose more than 7%
GLONGHUI March 8 | Boji Pharmaceuticals rose more than 7%, followed by Sanbo Neurology, Innovative Healthcare, Zhongke Information, and Nanjing Panda. According to the news, the first plenary meeting of the Brain-Computer Interface Industry Alliance in 2024 is about to be held, and the innovative results of the Brain-Computer Interface Industry Alliance will be announced.
Nanjing Panda Electronics Co., Ltd. (00553) plans to sell materials, parts and provide subcontract services to ENC and Lejin Panda respectively
Nanjing Panda Electronics Co., Ltd. (00553) announced that the company will hold the 10th board meeting on March 7, 2024...
Analysis
Price Target
No Data
